Asthma Intervention Programs for Asthma
(PR-AIR Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this study is to adapt and deliver an evidence-based multi-level intervention to reduce asthma disparities, and that promote and improve population health in the high-burden communities of San Juan, Puerto Rico. The Puerto Rico-Asthma Integrated Response Program (PR-AIR) will be implemented and evaluated to address pediatric asthma disparities in San Juan, PR, an area of high asthma burden. This study unfolds in two phases: In Phase 1, the researchers will collaborate with community stakeholders to identify needs, barriers and facilitators of PR-AIR implementation. Phase 2 consists of an evaluation of low-intensity (virtual) and high-intensity (in-person) methods of PR-AIR implementation outcomes using the RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) framework and a mixed methods approach.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment CASE and HARP for asthma?
Research on remote patient monitoring (RPM) for chronic conditions like heart failure and chronic obstructive pulmonary disease (COPD) shows that RPM can help reduce hospital visits and improve self-care. This suggests that similar remote monitoring approaches, like CASE-V and HARP-V, might also be beneficial for managing asthma.12345
How is the Asthma Intervention Programs treatment different from other asthma treatments?
The Asthma Intervention Programs treatment is unique because it offers both high and low intensity packages, with options for in-person and remote delivery, focusing on comprehensive patient education and support through a systems approach. This includes early diagnosis, use of oral steroids, and a nurse case manager to oversee patient care, which is not typically emphasized in standard asthma treatments.678910
Research Team
Daphne Koinis Mitchell, PhD
Principal Investigator
Rhode Island Hospital
Elizabeth L McQuaid, PhD, ABPP
Principal Investigator
Rhode Island Hospital
Ligia Chavez, PhD
Principal Investigator
University of Puerto Rico
Eligibility Criteria
This trial is for children aged 2-12 with not well controlled or poorly controlled asthma, living in specific areas of San Juan, Puerto Rico. It's not suitable for kids with complex medical conditions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Phase 1: Formative Evaluation
Researchers collaborate with community stakeholders to identify needs, barriers, and facilitators for PR-AIR implementation.
Phase 2: Low-Intensity Implementation
Families receive virtual interventions for asthma management.
Phase 2: High-Intensity Implementation
Families receive in-person interventions for asthma management.
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- CASE and HARP in person (High Intensity package)
- CASE in person version (High Intensity Package)
- CASE-V and HARP-V remote version (Low Intensity package)
- CASE-V remote version (Low Intensity Package)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rhode Island Hospital
Lead Sponsor
University of Puerto Rico
Collaborator